Copertina

Correction to “The Dynamics of Circulating Tumour DNA ( ctDNA ) During Treatment Reflects Tumour Response in Advanced Melanoma Patients”

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual‐Tumour Mouse Melanoma Model
di: Marine Delmas, et al.
Pubblicazione: (2025)

Precision at the Cutting Edge: Ex Vivo Confocal Microscopy for Perioperative Tumour Thickness Assessment in Melanoma
di: D. Hartmann, et al.
Pubblicazione: (2025)

Basophil‐Derived IL‐4 Production and Its Potential Pro‐Tumoural Role in Th2‐Polarisation Within Sentinel Lymph Nodes of Primary Cutaneous Melanoma
di: Aki Tajima, et al.
Pubblicazione: (2025)

Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma
di: Sayoni Roy, et al.
Pubblicazione: (2024)

Differential Tumour Necrosis Factor‐Like Weak Inducer of Apoptosis ( TWEAK ) Associations in Pemphigus and Bullous Pemphigoid
di: Shiran Kang, et al.
Pubblicazione: (2026)

PI3Kγ Deficiency Suppresses Cutaneous Squamous Cell Carcinoma Formation by Modulating the Tumour Microenvironment Rather Than by Directly Regulating Keratinocyte Proliferation
di: Aya Toyoshima, et al.
Pubblicazione: (2026)

Are There Socio‐Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review
di: Sarah Rae, et al.
Pubblicazione: (2026)

Dynamic Optical Coherence Tomography Enhances Melanoma Detection
di: Carmen Cantisani, et al.
Pubblicazione: (2025)

Real‐World Experience of 3‐Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis
di: Hideyuki Nakajima, et al.
Pubblicazione: (2024)

Matrix Metalloproteinase Inhibition in Melanoma
di: Ellie Zhang, et al.
Pubblicazione: (2026)

Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol
di: Taku Fujimura, et al.
Pubblicazione: (2026)

Determining a Stability Prognostic Panel for 636 Patients With Melanoma Using a Machine Learning Computational Framework
di: Hewen Guan, et al.
Pubblicazione: (2025)

A Genome‐Wide Survey of DNA Methylation Status in Whole Blood of Patients With Hidradenitis Suppurativa Suggests Systemic Immune Dysregulation and Systemic Disease Burden
di: Marco Montoya, et al.
Pubblicazione: (2025)

Analysis of the Dynamics of Clinical Parameters and Serum Angiogenic Factors in Systemic Sclerosis Patients Undergoing Tocilizumab Treatment
di: Yuichiro Segawa, et al.
Pubblicazione: (2026)

Circulating Interleukin‐6 and Janus Kinase 2 DNA Copies in Serum Cell‐Free DNA Are Elevated in Patients With Systemic Sclerosis
di: Hitomi Matsunaga‐Nakashima, et al.
Pubblicazione: (2025)

Changes in mouse epidermal DNA methylation during development of squamous cell carcinoma in response to UVR
di: Olivia Luxford Meyer, et al.
Pubblicazione: (2024)

Melanoma and cannabinoids: A possible chance for cancer treatment
di: Mariarosaria Galeano, et al.
Pubblicazione: (2024)

The Role of ROS ‐Mediated Mitochondrial Dysfunction in the Development of Malignant Melanoma
di: Lei Li, et al.
Pubblicazione: (2025)

Intravascular Tumour in a Dog Causing Skin Ulcerative Lesions
di: Alla Seleznova, et al.
Pubblicazione: (2025)

Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous Melanoma
di: Corinne I. Stoffel, et al.
Pubblicazione: (2025)

MCAM Expression Facilitates Melanoma–Endothelial Interactions and Promotes Metastatic Disease Progression
di: Andreas Dominik Braun, et al.
Pubblicazione: (2025)

CD 24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target
di: Claudia Lasalle, et al.
Pubblicazione: (2026)

The cross‐linking between DNA damage, oxidative stress and epidermal barrier in keratinocytes after exposure to particulate matters and carbon black
di: Jie Tang, et al.
Pubblicazione: (2024)

Severe Darier's Disease by Mitochondrial DNA Insertion Causing Nonsense Mutations: In Silico Prediction of a Pathophysiological Mechanism to a Novel Mutation
di: Haruna Shintani, et al.
Pubblicazione: (2025)

Identifying Anisotropic Structures of Non‐Stained Melanoma Tissue From Images of Its Mueller Matrix Elements
di: Xiupin Wu, et al.
Pubblicazione: (2026)

Reduced EZH2 Expression in Circulating CD8 ‐Positive T Cells and Monocytes in Psoriasis
di: Toyoki Yamamoto, et al.
Pubblicazione: (2026)

Gender Disparities in Melanoma: Advances in Diagnosis, Treatment, and the Role of Artificial Intelligence
di: Diala Ra'Ed Kamal Kakish, et al.
Pubblicazione: (2025)

Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment
di: Xiaomin Huang, et al.
Pubblicazione: (2025)

Treatment Recommendations Regarding Superficial BCC Should Not Be Based on the Challenges Encountered in a Select Group of Tumours That Were Referred for Moh's Micrographic Surgery
di: Robert Stephens
Pubblicazione: (2025)

Advances in the Characteristics of Fibroblasts in Keloid: A Review
di: Liangxinwen Lei, et al.
Pubblicazione: (2026)

Clinical, Dermoscopic and Reflectance Confocal Microscopy Characteristics Associated With the Presence of Negative Pigment Network Among Spitzoid Neoplasms
di: Marco Spadafora, et al.
Pubblicazione: (2025)

Reflectance confocal microscopy as a complementary diagnostic tool for vulvar lichen sclerosus and vulvar vitiligo in juvenile Chinese girls
di: Ying Wang, et al.
Pubblicazione: (2024)

Nail Involvement Among Psoriasis Patients: A Comparative Retrospective Cohort Analysis of 2888 Egyptian Patients
di: Nermeen Ibrahim Bedair, et al.
Pubblicazione: (2025)

Correction to ‘Dose escalation of biologic treatment in patients with moderate‐to‐severe psoriasis in Japan’
Pubblicazione: (2024)

Atypical Dermatophytosis in Patients Treated by JAK Inhibitors
di: Jen A. Barak Levitt, et al.
Pubblicazione: (2026)

Correction to ‘Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes’
Pubblicazione: (2025)

Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions
di: Tushar Madaan, et al.
Pubblicazione: (2024)

Clinical Experience of Risankizumab in Patients With a History of Erythrodermic Psoriasis
di: Che‐Chia Hsu, et al.
Pubblicazione: (2025)

A Novel Ammonium Carboxylate Salt of Undecylenic Acid for the Topical Treatment of Gram‐Positive and Antibiotic‐Resistant Skin Infections
di: Alyce Mayfosh, et al.
Pubblicazione: (2025)

Correction to ‘Senolytic Targeting of Anti‐Apoptotic Bcl Family Increases Cell Death in UV ‐Irradiated Senescent Melanocytes: Search for Senolytics’
Pubblicazione: (2026)